This special series on “Comprehensive care for patients with Hepatocellular Carcinoma: Insights from the 2022 San Antonio Liver Cancer Symposium” is edited by Dr. Sukeshi Patel Arora and Dr. Sherri Rauenzahn Cervantez.

Sukeshi Patel Arora, MD
Division of Hematology/Oncology, Department of Internal Medicine, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA

Dr. Sukeshi P. Arora is currently the Leader of GI Medical Oncology and Geriatric Oncology at Mays Cancer Center, and Associate Professor of Medicine at University of Texas Health San Antonio. She received her medical degree from University of Texas Southwestern Medical School, and completed Internal Medicine residency and Hematology/Oncology Fellowship at University of Texas Health San Antonio. She serves as the Chair of the Commission on Cancer at University Health System, San Antonio, and she chairs the GI Research Clinical Disease Site Team at Mays Cancer Center. She also serves on the Board of Young International Society of Geriatric Oncology (Young SIOG). Her research activities include drug development in GI malignancies, with a focus on liver cancer, as well as drug development in older adults with GI cancers.

Sherri Rauenzahn Cervantez, MD 
Medical Oncology, University of Texas Health San Antonio, San Antonio, TX, USA

Dr. Sherri Cervantez is a faculty member at UT Health San Antonio with joint appointment to the Division of Hematology and Oncology and the Division of Geriatrics, Gerontology, and Palliative Medicine. She earned her B.S. in neuroscience and behavioral biology from Emory University. She received her medical doctorate from Virginia Commonwealth University and completed her residency in internal medicine at West Virginia University. She completed a fellowship in Hospice and Palliative Medicine at Virginia Commonwealth University prior to completing her hematology and oncology fellowship at UT Health San Antonio. She joined UT Health San Antonio MD Anderson Cancer Center in 2017 as Director of Palliative Oncology. Her clinical interests include lung cancers, head and neck cancers, and palliative oncology.

Series outline:

1. Transplantation and HCC
2. Treatment of Localized HCC: Resection vs Ablation vs Radiation
3. Management of Cirrhosis during the Treatment of HCC
4. Sarcopenia and HCC
5. Rehabilitation in Patients with HCC
6. Novel Therapeutics in Advanced HCC
7. Multi-disciplinary Care for Patients with HCC
8. Multifocal HCC: Treatment Options
9. Hepatorenal Syndrome and HCC
10. Supportive and End of Life Care Considerations in Advanced HCC
11. Management of Autoimmune & Viral Hepatitis in the Setting of Immunotherapy

Disclosure:
The series “Comprehensive care for patients with Hepatocellular Carcinoma: Insights from the 2022 San Antonio Liver Cancer Symposium” was commissioned by the editorial office, Annals of Palliative Medicine without any sponsorship or funding. Sukeshi Patel Arora and Sherri Rauenzahn Cervantez are serving as unpaid Guest Editors for the series.